New Horizons of Therapeutic targets in Antiviral Drug Discovery

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

RBVRR WOMEN’S COLLEGE OF PHARMACY,Barkatpura, Hyderabad
Feedback form : Dt 13th,Oct,2020
Session no1: Role of machine learning and Computational Resources in antiviral drug discovery and development

Email *

1. Name of the participant and Institute *

2.Methodology for development of alogirthm starts from *

loading the properties into the software

cross validation

Calculation of properties of target

development of viral algorithm

3.Targets can be selected by intervention of viral cycle by identifying *

Inhibitors at entry level

Inhibitors at translation level

Polymerase inhibitors

All the above

4.Best webserver used for antiviral drugs *

AVPpred

SwissProt

D3Targets-2019-nCoV

None of the above

5.Mark the algorithm used for Chemical modification of siRNA *

VIRsiRNAPRED

siRNAMOD

HIVsirDB

None of the above

6.Mark the inhibitor of the host against virus *

Host proteins

VIRmiRNA

Host nucleic acid

None of the above

7.Mark the first database developed using CRISPR for antiviral drugs *

CoronaVR

HIVpred

CRISPRge

Anti flavi

8. Mark the algorithm for protease inhibitors *

Anti flavi

anti nipah

HIVpred

None of the above

9.Present day repurposing drugs are used against inhibiting *

Host proteins

viral translation process

Polymerase inhibitors

Protease inhibitors

10.How would you rate the speaker? *

Submit

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy

Forms